ArticleCancers2021

Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study.

Pilar García-Alfonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.